People: Allergan Inc (AGN.N)

AGN.N on New York Stock Exchange

226.51USD
11:42am EST
Change (% chg)

$-1.32 (-0.58%)
Prev Close
$222.79
Open
$225.66
Day's High
$227.28
Day's Low
$225.63
Volume
92,925
Avg. Vol
371,777
52-wk High
$228.43
52-wk Low
$110.62

Search Stocks

McDonnell, Peter 

Brief Biography

Dr. Peter J. McDonnell, M.D., is Independent Director of Allergan Inc. He has served as the Director and William Holland Wilmer Professor of the Wilmer Eye Institute of the Johns Hopkins University School of Medicine since 2003, where he leads the Wilmer Eye Institute. Dr. McDonnell has also served as the Chief Medical Editor of Ophthalmology Times since 2004, and has served on the editorial boards of numerous ophthalmology journals. He served as a consultant to the United States Department of Health and Human Services in 1996 and also served as the Assistant Chief of Service at the Wilmer Institute from 1987 to 1988. Dr. McDonnell is a Member of the American Academy of Ophthalmology, American University Professors of Ophthalmology, Association for Research in Vision and Ophthalmology, Maryland Society of Eye Physicians and Surgeons, and Pan American Association of Ophthalmology. In 1999, Dr. McDonnell was named the Irving H. Leopold Professor and Chair of the Department of Ophthalmology at the University of California — Irvine. He is the recipient of research grants from the National Eye Institute, Research to Prevent Blindness, and other funding agencies. The American Academy of Ophthalmology honored him with the Honor Award in 1991 and the Senior Achievement Award in 2001. Dr. McDonnell serves as a board member of the National Alliance for Eye and Vision Research and the Doheny Eye Institute, and is a former member of the board of Tissue Banks International. Dr. McDonnell was appointed to Board in January 2013, is a member of the Corporate Governance and Compliance Committee and Science & Technology Committee.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

David Pyott

12,029,300

Douglas Ingram

3,576,040

James Hindman

--

Scott Whitcup

2,913,090

Arnold Pinkston

--

Scott Sherman

--
As Of 30 Dec 2013
Search Stocks